Problem
You are coordinating a community-clinic based program which has just started testing a novel antibiotic that offers promise for treating community-acquired pneumonia. After 200 patients have been treated successfully with no apparent adverse effect, you discover that two of the newer patients enrolled in the trial have developed anemia, after taking the drug for seven days What are possible explanations for these results and how would you proceed to confirm them? What actions would you take next?